MESQUITE SPECIALTY HOSPITAL — History
CCN 452100 | 3-year financial timeline | COVID resilience: 23/100
🛡️ Public data only — no PHI permitted on this instance.
$13M
Latest Revenue (FY2022)
-7.5%
Revenue CAGR (3yr)
-25.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $12M | $13M | +7.3% | -7.5% |
| Operating Expenses | $17M | $16M | $16M | +4.8% | -0.5% |
| Operating Margin | -8.4% | -28.5% | -25.5% | +10.5% | +0.0% |
| Net Income | $-1M | $-3M | $-3M | +3.9% | +0.0% |
| Licensed Beds | 40 | 40 | 40 | +0.0% | +0.0% |
| Total Patient Days | 8,976 | 6,560 | 7,199 | +9.7% | -10.4% |
| Medicare Day % | 59% | 55% | 58% | +4.0% | -0.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 23/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -14.4% ($15M → $13M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-7.5%
This Hospital
+7.6%
State Avg
Latest Margin
-25.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $12M | -34.1% |
| FY2024 (proj) | $11M | -42.6% |
| FY2025 (proj) | $10M | -51.2% |